Leal Therapeutics
PrivateLast Round
Series A
Aug 27, 2025
Total Funding Raised
$147M
Momentum
Top 25%
of companies Caplight tracks
Company Overview
Leal Therapeutics is a biotechnology company that develops innovative neuro-metabolic therapeutic solutions for major central nervous system conditions.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Clinical Trials
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Leal Therapeutics Comps
Public and private peers based on sector, stage, and business model.
| Company | Status | Est. Valuation | Rev Multiple |
|---|---|---|---|
| OpenAI | Private | $86.0B | ~40x |
| Cohere | Private | $5.0B | -- |
| Competitor 1 | Public | $XX.XB | XXx |
| Competitor 2 | Public | $XX.XB | XXx |
Leal Therapeutics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series A | Aug 27, 2025 | ||||
| VC Round | Oct 30, 2024 |
Key People
Founding team and executive leadership
Leal Therapeutics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Newpath Partners | Series A, VC Round |
| SV Health Investors | Series A |
| OrbiMed | Seed, Series A, VC Round |
| Chugai Venture Fund | Series A, VC Round |
| Alexandria Venture Investments | Series A, VC Round |
| PhiFund Ventures | Seed, Series A, VC Round |
| Euclidean Capital | VC Round, Series A, Seed |
Market signals
Structured signals derived from secondary market and firmographic data.
- Apr 13, 2026
Raymond Jordt appointed as new Chief Business Officer.
- Apr 13, 2026
Johannes Tauscher, M.D. appointed as new CMO.
Leal Therapeutics Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Leal Therapeutics's valuation, stock price, and market status.